Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 1;72(11):e750-e752.
doi: 10.1093/cid/ciaa1705.

Compiling Observational Research During a Pandemic: A Necessary Bridge

Rebekah W Moehring  1   2 , Thomas L Holland  1   3
Affiliations
Editorial

Compiling Observational Research During a Pandemic: A Necessary Bridge

Rebekah W Moehring et al. Clin Infect Dis. .
No abstract available

Keywords: COVID-19; IL-6 receptor antagonists; observational; tocilizumab.

PubMed Disclaimer

Comment on

References

    1. Kouzy R, Abi Jaoude J, Garcia Garcia CJ, El Alam MB, Taniguchi CM, Ludmir EB. Characteristics of the multiplicity of randomized clinical trials for coronavirus disease 2019 launched during the pandemic. JAMA Netw Open 2020; 3:e2015100. - PMC - PubMed
    1. Hermine O, Mariette X, Tharaux P-L, et al. . Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med 2020: E1–8. doi:10.1001/jamainternmed.2020.6820. - DOI - PMC - PubMed
    1. Salvarani C, Dolci G, Massari M, et al. . Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial. JAMA Intern Med 2020: E1–8. doi:10.1001/jamainternmed.2020.6615. - DOI - PMC - PubMed
    1. Stone JH, Frigault MJ, Serling-Boyd NJ, et al. . Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med 2020: 1–12. doi:10.1056/NEJMoa2028836. - DOI - PMC - PubMed
    1. Gupta S, Wang W, Hayek SS, et al. . Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med 2020: E1–E11. doi:10.1001/jamainternmed.2020.6252. - DOI - PMC - PubMed

Substances